Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

Rhea-AI Summary

Deciphera Pharmaceuticals (NASDAQ: DCPH) announces Steve Hoerter, President and CEO, will join a fireside chat at the Barclays Global Healthcare Conference on March 9, 2021, at 1:50 PM ET in a virtual format.

A live webcast will be available on the company’s website, with a replay accessible for 90 days after the presentation. Deciphera focuses on developing innovative medicines for cancer treatment, leveraging its proprietary switch-control kinase inhibitor platform. Their product, QINLOCK, is FDA-approved for fourth-line gastrointestinal stromal tumor treatment.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 PM ET. The conference will be held in a virtual meeting format.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia. For more information, visit www.deciphera.com and follow us on LinkedIn and Twitter (@Deciphera).

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005243/en/

FAQ

When is the Barclays Global Healthcare Conference where DCPH will be participating?

The Barclays Global Healthcare Conference will take place on March 9, 2021.

What time will Steve Hoerter speak at the Barclays Conference?

Steve Hoerter will participate at 1:50 PM ET.

How can I watch the DCPH fireside chat at the Barclays Conference?

You can watch the live webcast on the 'Events and Presentations' page in the Investors section of Deciphera's website.

Will there be a replay available for the DCPH conference presentation?

Yes, a replay of the webcast will be available for 90 days after the presentation.

What is QINLOCK and its approval status?

QINLOCK is Deciphera's FDA-approved kinase inhibitor for fourth-line gastrointestinal stromal tumor treatment.